These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 19911877)

  • 1. Challenges and advances in nanoparticle-based oral insulin delivery.
    Ramesan RM; Sharma CP
    Expert Rev Med Devices; 2009 Nov; 6(6):665-76. PubMed ID: 19911877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle strategies for the oral delivery of insulin.
    Damgé C; Reis CP; Maincent P
    Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering strategies to enhance nanoparticle-mediated oral delivery.
    Yamanaka YJ; Leong KW
    J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the efficacy and safety of nanoparticle-based oral insulin delivery systems.
    Card JW; Magnuson BA
    Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G956-67. PubMed ID: 21921287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric core-shell nanoparticles for therapeutics.
    Yang YY; Wang Y; Powell R; Chan P
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):557-62. PubMed ID: 16700894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery.
    Chen MC; Sonaje K; Chen KJ; Sung HW
    Biomaterials; 2011 Dec; 32(36):9826-38. PubMed ID: 21925726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colloidal carrier integrating biomaterials for oral insulin delivery: Influence of component formulation on physicochemical and biological parameters.
    Woitiski CB; Neufeld RJ; Ribeiro AJ; Veiga F
    Acta Biomater; 2009 Sep; 5(7):2475-84. PubMed ID: 19362890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
    Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
    Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral delivery of proteins by biodegradable nanoparticles.
    Bakhru SH; Furtado S; Morello AP; Mathiowitz E
    Adv Drug Deliv Rev; 2013 Jun; 65(6):811-21. PubMed ID: 23608641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in recognitive, conductive and responsive delivery systems.
    Bayer CL; Peppas NA
    J Control Release; 2008 Dec; 132(3):216-21. PubMed ID: 18652857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles for drug delivery to the lungs.
    Sung JC; Pulliam BL; Edwards DA
    Trends Biotechnol; 2007 Dec; 25(12):563-70. PubMed ID: 17997181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
    Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY
    Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
    Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
    Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
    J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
    Gaumet M; Vargas A; Gurny R; Delie F
    Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle technologies for cancer therapy.
    Alexis F; Pridgen EM; Langer R; Farokhzad OC
    Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarriers.
    Torchilin VP
    Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.
    Merisko-Liversidge E; Liversidge GG
    Adv Drug Deliv Rev; 2011 May; 63(6):427-40. PubMed ID: 21223990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.